OncoGenomX is a Swiss developer of precision cancer treatment software. Augmented by AI and machine learning the software identifies efficacious treatment – tumor pairings.

Clinical decision support augmented by our software empowers determination of the correct treatment required by a patient/tumor for durable metastasis prevention.

Vision: Omission of uncertainty from clinical decision support and randomness from therapy choice.

Mission: Becoming the Number 1 test for durable metastasis prevention, any given patient.

Together with our alliance partners, we are committed to game-changing software innovations - For value-based care, longer, healthier, and better lives of women with breast cancer.